tiprankstipranks
Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA
Holding SNOA?
Track your performance easily

Sonoma Pharmaceuticals (SNOA) Financial Statements

279 Followers

Sonoma Pharmaceuticals Financial Overview

Sonoma Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.887; its P/E ratio is -0.57; Sonoma Pharmaceuticals is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is $-0.69. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 3.58M$ 3.39M$ 3.44M$ 3.14M$ 2.73M
Gross Profit$ 1.36M$ 1.31M$ 1.09M$ 1.46M$ 990.00K
EBIT$ -463.00K$ -997.00K$ -1.36M$ -844.00K$ -1.21M
EBITDA$ -428.00K$ -958.00K$ -1.32M$ -799.00K$ -1.16M
Net Income Common Stockholders$ -610.00K$ -1.14M$ -1.07M$ -866.00K$ -1.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.08M$ 2.59M$ 3.13M$ 2.41M$ 2.14M
Total Assets$ 13.69M$ 13.67M$ 14.74M$ 14.62M$ 13.63M
Total Debt$ 244.00K$ 420.00K$ 608.00K$ 385.00K$ 522.00K
Net Debt$ -3.83M$ -2.17M$ -2.52M$ -2.02M$ -1.61M
Total Liabilities$ 8.33M$ 8.70M$ 8.60M$ 7.93M$ 7.96M
Stockholders Equity$ 5.35M$ 4.97M$ 6.14M$ 6.69M$ 5.67M
Cash Flow-
Free Cash Flow$ 328.00K$ -917.00K$ 155.00K$ -1.10M$ -1.23M
Operating Cash Flow$ 354.00K$ -912.00K$ 152.00K$ -1.10M$ -1.23M
Investing Cash Flow$ -26.00K$ -5.00K$ 18.00K$ -1.00K$ -2.00K
Financing Cash Flow$ 1.44M$ 636.00K$ 622.00K$ 1.32M$ -129.00K
Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History

Sonoma Pharmaceuticals Debt to Assets

Sonoma Pharmaceuticals Cash Flow

Sonoma Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis